Access to Healthcare
Commitment to Affordable Medication
As a leading generic pharmaceutical company, Mega Lifesciences' primary commitment is to provide high-quality medications at a fraction of the cost of brand-name drugs. By focusing on the production and strategic sourcing of generics, we can significantly reduce the financial burden on patients and healthcare systems. Our pricing strategy is guided by the principle that no one should be denied access to essential medications due to cost considerations.
Mega participates in competitive tenders on a fair basis and occasionally wins the tenders thereby participating in opportunities to reduce costs of healthcare. Mega Lifesciences has successfully supplied against tenders in Malaysia, Vietnam, Tanzania and several other countries through competitive bidding. This forms a very small part of business but Mega has contributed to such tenders.
Ensuring Quality and Safety
Quality and safety are at the core of Mega Lifesciences' operations. We adhere to stringent regulatory standards and employ advanced manufacturing processes to ensure that our products meet the highest quality benchmarks. Each medication undergoes rigorous testing and quality control measures to guarantee its efficacy and safety. By maintaining these high standards, we build trust with healthcare providers and patients, assuring them that our generics are reliable alternatives to brand-name drugs.
Mega Lifesciences owns 4 facilities in Thailand, Indonesia and Australia. The facilities are certified by reputed organizations like TGA, EU, Thailand and African region regulatory authorities.
Mega Lifesciences has successfully completed 6 audits during 2023 and 1 audit during 2024 by regulatory bodies from Australia, Thailand, Kenya, Yemen, Germany (BfArm) and Ukraine.
Expanding Global Reach
Access to healthcare is a global issue, and Mega Lifesciences' efforts extend beyond national borders. We strive to reach underserved populations in MLIC markets by partnering with local governments, non-governmental organizations, and international health agencies. Through these collaborations, we aim to distribute our medications to areas where they are needed the most, addressing disparities in healthcare access on a global scale.
- Mega supplies to more than
- The company has a presence in more than
in ASEAN, Sub-Saharan Africa, Srilanka and Ukraine.
All Business Revenue Split
| Figures in THB | FY 2023 | FY 2022 |
|---|---|---|
| Thailand | 2,362,715,181 | 2,736,143,940 |
| Other than Thailand | 13,318,456,804 | 12,950,079,572 |
| Total | 15,681,171,985 | 15,686,223,512 |
Brand Business revenue Split
| Figures in THB | FY 2023 | FY 2022 |
|---|---|---|
| Thailand | 2,353,925,092 | 2,727,275,392 |
| Other than Thailand | 5,650,857,600 | 5,325,492,791 |
| Total | 8,004,782,692 | 8,052,768,183 |
Brand Revenue by Category
| Figures in THB | FY 2023 | FY 2022 |
|---|---|---|
| Nutraceutical (1) | 4,335,181,585 | 4,639,304,511 |
| Prescription (2) | 2,672,565,772 | 2,399,818,363 |
| Self Medication (3) | 997,035,336 | 1,013,645,309 |
| Total | 8,004,782,692 | 8,052,768,183 |
(1) General health/Immunity, gastroenterology, dermatology, men’s/women health, cough/cold, bone health, probiotics and herbal medicines are the key therapeutic categories.
(2) Diabetology, dermatology, gastroenterology, Urology, cardiology, oncology and orthopedics are the key therapeutic categories.
(3) Analgesics, respiratory, gastroenterology, pain management and cough and cold are the key therapeutic categories.
Partnerships and Collaborations
Our partnerships are integral to our mission of improving access to healthcare. We work closely with a network of stakeholders, including healthcare providers, pharmacies, and patient advocacy groups, to ensure that our medications are available and accessible. These collaborations enable us to understand the unique needs of different communities and tailor our distribution strategies accordingly.
We have technology transfer arrangements with companies in Vietnam, South Africa and potentially in few markets of Sub-Saharan Africa to promote local manufacturing and supply.
Local Manufacturing and Distribution
To enhance our global reach, Mega Lifesciences invests in local manufacturing and distribution facilities in key regions. By establishing a local presence, we can reduce supply chain disruptions, lower transportation costs, and accelerate the delivery of medications to patients. This localized approach also helps us comply with regional regulatory requirements and adapt to the specific healthcare needs of each market.
We follow a replenishment model and hence Mega experiences no or negligible cases of stock out.
Innovating for Better Health
Innovation is a driving force behind Mega Lifesciences' efforts to improve access to healthcare. We continuously invest in research and development to bring new generic formulations to market, including biosimilars and complex generics. By expanding our product portfolio, we can address a broader range of medical conditions and provide more treatment options for patients.
Research and Development Initiatives
Embracing Technological Advancements
Advocating for Policy Changes
Policy advocacy is a crucial aspect of Mega Lifesciences' efforts to improve access to healthcare. We actively engage with policymakers, industry associations, and regulatory bodies to promote policies that support the availability and affordability of generic medications. Our advocacy initiatives focus on reducing barriers to market entry, ensuring fair pricing regulations, and promoting the use of generics in healthcare systems.
Collaborating with Regulators
We collaborate with regulatory authorities to streamline the approval process for generic medications. By working together, we can expedite the availability of generics and ensure that patients have timely access to essential treatments. Our regulatory affairs team is dedicated to maintaining compliance with all relevant guidelines and standards, fostering a transparent and efficient approval process.
Supporting Healthcare Reforms
We support healthcare reforms that prioritize patient access to affordable medications. This includes advocating for policies that incentivize the use of generics, increase funding for public healthcare programs, and promote equitable access to treatments. Through our advocacy efforts, we aim to create a healthcare landscape where cost is not a barrier to receiving quality care. Mega Lifesciences has advocated for revision of patents regime in Ukraine to allow generic players to register their products before expiry of patent and available for sale immediately on expiry of patents. Mega has joined a group of pharmaceutical companies to advocate for changes in law for selling pharma products by foreign owned company especially those companies that are invested like Mega Lifesciences.
Sub-standard medications and duplicate products
Mega Lifesciences has diligently reported sub-standard/ duplicate/ unauthorized medications to the local regulators and in the recent past we have identified such products and reported to the competent regulatory authorities in several countries including Nigeria, Malaysia and in Thailand.
Empowering Patients and Communities
Empowering patients and communities is at the heart of Mega Lifesciences' mission. We believe that informed patients are better equipped to make decisions about their health and treatment options. To this end, we invest in educational initiatives and outreach programs that raise awareness about the benefits of generics and provide information on how to access our medications.
Patient Education and Awareness
We develop educational materials and resources to inform patients about the safety, efficacy, and cost-effectiveness of generic medications. Our outreach efforts include community workshops, informational campaigns, and partnerships with healthcare providers to disseminate this information. By empowering patients with knowledge, we enable them to make informed choices about their healthcare.
Mega has a We Care page on the site www.megawecare.com which has a base of 1 million followers and 1.5 million unique users recording an increase of 20% compared to previous year.
Community Outreach Programs
Our community outreach programs aim to address the specific healthcare needs of underserved populations. We collaborate with local organizations to provide health screenings, medical camps, and free medication distribution events. These initiatives help us reach vulnerable communities and ensure that they receive the care and treatments they need.
Wellness We Care Centre (‘WWCC’) in Muak Lek, Thailand is helping community to deal with non-communicable disease and is helping those affected with disease reversal through the Good Health By Yourself (GHBY) program. https://www.megawecare.com/good-health-by-yourself WWCC has been set up for disease reversal and good health through proper lifestyle.
Every hour 43 Thai people die from non-communicable diseases (NCDs), causing an estimate of 380,000 deaths or 76% of all deaths each year. The rise in NCDs does not only increase financial, physical and mental costs in families, but it also extends beyond the people who are directly affected. Costly chronic diseases also lead to a decline in the working-age population of the labor force, which reduces productivity and results in the decrease of GDP per capita growth. According to the World Health Organization (WHO), NCDs pose a real and significant threat to Thailand, with a huge economic burden costing Thai society an estimated THB 280 billion in 2013. In 2009, the economic cost of NCDs was an estimated THB 198,512 million, or 2.2% of GDP, due to premature deaths and loss of productivity among the country’s work force. With serious ailments, many physical and emotional losses may come before the loss of life itself. One of the major behavioral risk factors of NCDs is an unhealthy diet. People are adopting a more sedentary lifestyle which contribute to a steady increase in long-term health problems and double the risk of cardiovascular diseases, diabetes, and obesity. Mega Lifesciences goal is to help people stay healthy as long as they live. We believe in building holistic health in communities we live and work in, as healthy population means happiness and prosperity to Individual, family, society and nation.
Aligned to this goal Mega has built The Wellness We Care Center, located at Amphur Muak Lek, Saraburi, to promote to common people and health care providers around the work, scientifically proven method of preventing and reversing chronic diseases through food and lifestyle changes. The foremost objective of Wellness We Care is to disseminate scientific knowledge and skills to people, which will help them to take charge of their own health. By teaching people about lifestyle changes, the center helps them develop the skills necessary for prevention and reversal of chronic and lifestyle diseases. Our holistic health center offers guests access to the various wellness center services such as the Praana Kitchen, where they can learn to cook plant-based whole food meals, and the vegetable garden. The center is also equipped with a well-stocked library and video room, where visitors can learn and enhance their knowledge about health and holistic living.
Onsite Training
| Year | No. of training sessions | No. of hours | No. of participants |
|---|---|---|---|
| 2019 | 34 | 1,008 | 520 |
| 2020 | 26 | 888 | 495 |
| 2021 | 20 | 552 | 396 |
| 2022 | 28 | 584 | 605 |
| 2023 | 47 | 1,136 | 915 |
Online Health Educational VDOs
Year 2021
Year 2022
Year 2023
| Health Camps | Number of times the camp is held | Number of participants | Target Groups |
|---|---|---|---|
| 1. Good Health by Yourself (GHBY) | 8 | 169 | General public and organizations |
| 2. Reverse Disease by Yourself (RDBY) | 4 | 73 | NCD Patients, and care givers |
| 3. Spiritual Retreat (SR) | 10 | 215 | General public and organizations |
| 4. Senior Quality Life (SQL) | 6 | 110 | General public and organizations |
| 5. Cancer Retreat (CR) | 3 | 43 | Cancer patients, and care givers |
| 6. Pre-retirement (PRC) | 2 | 34 | General public and organizations |
| 7. Plant-Based Cooking Camp | 5 | 69 | General public and organizations |
| 8. Good Sleep by Yourself | 1 | 7 | General public and organizations |
| 9. Camp for Coach | 1 | 34 | General public and organizations |
| 10. Reverse Weight by Yourself | 2 | 30 | General public and organizations |
| 11. Camp for Medical Doctors | 1 | 37 | Medical doctors |
| 12. Camp for Executives | 1 | 23 | Corporate executives |
| 13. Manage Stress by Yourself | 1 | 29 | General public and organizations |
| 14. DM Camp | 1 | 1136 | Diabetic patients |
| 15. Camp for Lifestyle Medicine Physicians | 1 | 15 | Medical doctors |
| Total | 47 | 915 |
Improving access to healthcare is a multifaceted challenge that requires a comprehensive and collaborative approach. As a generic pharmaceutical company, Mega Lifesciences is committed to providing affordable, high-quality medications to patients around the world. Through our efforts in manufacturing, distribution, innovation, policy advocacy, and patient empowerment, we strive to make healthcare more accessible and equitable for all. Together with our partners, we will continue to work towards a future where everyone has the opportunity to live a healthy and fulfilling life.